APGE
Price
$40.59
Change
+$0.32 (+0.79%)
Updated
Mar 12, 01:38 PM (EDT)
Capitalization
2.34B
68 days until earnings call
KYMR
Price
$33.93
Change
+$0.66 (+1.98%)
Updated
Mar 12, 02:03 PM (EDT)
Capitalization
2.16B
50 days until earnings call
Ad is loading...

APGE vs KYMR

Header iconAPGE vs KYMR Comparison
Open Charts APGE vs KYMRBanner chart's image
Apogee Therapeutics
Price$40.59
Change+$0.32 (+0.79%)
Volume$307
Capitalization2.34B
Kymera Therapeutics
Price$33.93
Change+$0.66 (+1.98%)
Volume$470
Capitalization2.16B
APGE vs KYMR Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. KYMR commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and KYMR is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (APGE: $40.33 vs. KYMR: $33.26)
Brand notoriety: APGE and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 156% vs. KYMR: 129%
Market capitalization -- APGE: $2.34B vs. KYMR: $2.16B
APGE [@Biotechnology] is valued at $2.34B. KYMR’s [@Biotechnology] market capitalization is $2.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 5 bearish.
  • KYMR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а +32.80% price change this week, while KYMR (@Biotechnology) price change was +8.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.20%. For the same industry, the average monthly price growth was -6.76%, and the average quarterly price growth was -8.01%.

Reported Earning Dates

APGE is expected to report earnings on May 19, 2025.

KYMR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.34B) has a higher market cap than KYMR($2.16B). APGE YTD gains are higher at: -10.971 vs. KYMR (-17.325). KYMR (-160.96M) and APGE (-169.13M) have comparable annual earnings (EBITDA) . KYMR (550M) and APGE (526M) have equal amount of cash in the bank . APGE has less debt than KYMR: APGE (12.1M) vs KYMR (88.2M). KYMR has higher revenues than APGE: KYMR (87.6M) vs APGE (0).
APGEKYMRAPGE / KYMR
Capitalization2.34B2.16B108%
EBITDA-169.13M-160.96M105%
Gain YTD-10.971-17.32563%
P/E RatioN/AN/A-
Revenue087.6M-
Total Cash526M550M96%
Total Debt12.1M88.2M14%
TECHNICAL ANALYSIS
Technical Analysis
APGEKYMR
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
78%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMDVX17.49N/A
N/A
Hartford Schroders US MidCap Opps A
GIZCX12.42N/A
N/A
Invesco Global Infrastructure C
MDDIX9.73N/A
N/A
MassMutual Diversified Value I
FSPSX51.85N/A
N/A
Fidelity International Index
RSDQX23.93N/A
N/A
Invesco Rising Dividends R5

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+7.43%
SYRE - APGE
48%
Loosely correlated
-0.43%
ATXS - APGE
47%
Loosely correlated
+11.34%
KRYS - APGE
46%
Loosely correlated
+0.61%
KYMR - APGE
45%
Loosely correlated
+0.73%
ABOS - APGE
44%
Loosely correlated
+6.67%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.73%
CCCC - KYMR
59%
Loosely correlated
-4.86%
IMNM - KYMR
49%
Loosely correlated
-1.36%
RYTM - KYMR
48%
Loosely correlated
+3.07%
ERAS - KYMR
48%
Loosely correlated
+7.69%
NRIX - KYMR
47%
Loosely correlated
+2.28%
More